Abstract
Nitroxyl (HNO), the one electron reduced form of nitric oxide (NO), shows a very distinct chemistry and biology from that of NO. Chemical profile is characterized by reactions with thiols and thiol proteins such as aldehyde dehydrogenase, glyceraldehyde 3-phosphate dehydrogenase, caspases among others. Biological profile of HNO includes cardioprotective actions especially in cases of heart failure. This short review focuses on the cytotoxic properties for HNO. Nitroxyl was found to be toxic to several cancer cell lines including lung and breast cancers. Critical thiols that control cancer cellular functions might be the target for HNO activity. The anti-tumor actions of HNO donating aspirin is also summarized.
Keywords: Nitroxyl, HNO, Anti-cancer, Nitric oxide, Angeli’s salt, IPA/NO-aspirin.
Graphical Abstract
Current Topics in Medicinal Chemistry
Title:Nitroxyl (HNO): A Possible Strategy for Fighting Cancer
Volume: 16 Issue: 22
Author(s): Mai E. Shoman and Omar M. Aly
Affiliation:
Keywords: Nitroxyl, HNO, Anti-cancer, Nitric oxide, Angeli’s salt, IPA/NO-aspirin.
Abstract: Nitroxyl (HNO), the one electron reduced form of nitric oxide (NO), shows a very distinct chemistry and biology from that of NO. Chemical profile is characterized by reactions with thiols and thiol proteins such as aldehyde dehydrogenase, glyceraldehyde 3-phosphate dehydrogenase, caspases among others. Biological profile of HNO includes cardioprotective actions especially in cases of heart failure. This short review focuses on the cytotoxic properties for HNO. Nitroxyl was found to be toxic to several cancer cell lines including lung and breast cancers. Critical thiols that control cancer cellular functions might be the target for HNO activity. The anti-tumor actions of HNO donating aspirin is also summarized.
Export Options
About this article
Cite this article as:
Shoman E. Mai and Aly M. Omar, Nitroxyl (HNO): A Possible Strategy for Fighting Cancer, Current Topics in Medicinal Chemistry 2016; 16 (22) . https://dx.doi.org/10.2174/1568026616666160212123006
DOI https://dx.doi.org/10.2174/1568026616666160212123006 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Theranostic Applications of Lutetium-177 in Radionuclide Therapy
Current Radiopharmaceuticals Redox Environment and its Meaning for Breast Cancer Cells Fate
Current Cancer Drug Targets The AmpliChip: A Review of its Analytic and Clinical Validity and Clinical Utility
Current Drug Safety Bombesin-like Peptides: Candidates as Diagnostic and Therapeutic Tools
Current Pharmaceutical Design Nitric Oxide and Inflammation
Inflammation & Allergy - Drug Targets (Discontinued) Mechanistic Insight of Drug Resistance with Special Focus on Iron in Estrogen Receptor Positive Breast Cancer
Current Pharmaceutical Biotechnology Methods to Access 2-aminobenzimidazoles of Medicinal Importance
Current Organic Chemistry The Role of Integrin-Mediated Cell Adhesion in Atherosclerosis: Pathophysiology and Clinical Opportunities
Current Pharmaceutical Design Biological Strategies to Enhance Rotator Cuff Healing.
Current Stem Cell Research & Therapy Dietary Nitrite in Nitric Oxide Biology: A Redox Interplay with Implications for Pathophysiology and Therapeutics
Current Drug Targets Fused Xanthone Derivatives as Antiproliferative Agents
Anti-Cancer Agents in Medicinal Chemistry A Review on Natural Sources Derived Protein Nanoparticles as Anticancer Agents
Current Topics in Medicinal Chemistry Curcumin Suppresses Tumor Growth and Angiogenesis in Human Glioma Cells Through Modulation of Vascular Endothelial Growth Factor/ Angiopoietin-2/Thrombospondin-1 Signaling
CNS & Neurological Disorders - Drug Targets The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications
Current Cancer Drug Targets Recent Patents on Live Bacteria and their Products as Potential Anticancer Agents
Recent Patents on Anti-Cancer Drug Discovery Delivery of Therapeutics and Molecules Using Self-Assembled Peptides
Current Medicinal Chemistry Development and Applications of Optical Imaging Techniques in Cancer Diagnosis: Diffuse Optical Tomography and Microendoscopy
Current Medical Imaging Disposition of Pharmacologically Active Dietary Isoflavones in Biological Systems
Current Drug Metabolism Antitumor Pharmacology - Quo Vadis ?
Current Medicinal Chemistry - Anti-Cancer Agents Polysaccharide-K (PSK) in Cancer - Old Story, New Possibilities?
Current Medicinal Chemistry